Table 7.
Resveratrol in clinical trials.
| Drug | Conditions | Status | NCT number | Phases |
|---|---|---|---|---|
| Resveratrol and midazolam | Healthy | Completed | NCT01173640 | |
| Resveratrol | Cognitive and cerebral blood flow | Completed | NCT01010009 | |
| Resveratrol | Cardiovascular diseases | Completed | NCT01449110 | Phase 2 |
| Resveratrol | Colon cancer | Completed | NCT00256334 | Phase 1 |
| Resveratrol | Chronic subclinic inflammation | Completed | NCT01492114 | Phase 3 |
| Resveratrol | Type 2 diabetes mellitus | Completed | NCT01038089 | |
| Resveratrol | Healthy | Completed | NCT01331382 | |
| Resveratrol | Sports concussion | Completed | NCT01321151 | Phase 1 |
| Resveratrol | Neoplasms, colorectal cancer | Completed | NCT00920803 | Phase 1 |
| Resveratrol | Sedentary lifestyle | Completed | NCT01615445 | Phase 2 |
| Resveratrol | Melanoma (skin) | Completed | NCT00721877 | Phase 1 |
| Resveratrol | Metabolic syndrome, obesity | Completed | NCT01150955 | |
| Resveratrol | Multiple myeloma | Terminated | NCT00920556 | Phase 2 |
| Resveratrol | Healthy | Completed | NCT01640197 | Phase 1 |
| Resveratrol | Colorectal cancer | Completed | NCT00433576 | Phase 1 |
| Resveratrol | Unspecified adult solid tumor | Completed | NCT00098969 | Phase 1 |
| Resveratrol | Obesity, metabolic syndrome, diabetes | Completed | NCT00823381 | |
| Resveratrol | Obesity | Completed | NCT00998504 | |
| Resveratrol | Cardiovascular disease | Completed | NCT01199549 | |
| Resveratrol | Cellulite (orange peel skin) | Terminated | NCT01321268 | |
| Resveratrol | Type 2 diabetes | Completed | NCT00937222 |